The path toward using microbial metabolites as therapies | EBioMedicine – Thaiss Lab

The path toward using microbial metabolites as therapies | EBioMedicine

IL-23-producing IL-10Rα-deficient gut macrophages elicit an IL-22-driven proinflammatory epithelial cell response | Science Immunology

The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs | Science Translational Medicine

Growth dynamics of gut microbiota in health and disease inferred from single metagenomic samples | Science

Microbiota Diurnal Rhythmicity Programs Host Transcriptome Oscillations | Cell

2016, Highlights

Metagenomic cross-talk: the regulatory interplay between immunogenomics and the microbiome | Genome Medicine

Intestinal Tolerance, with a Little Help from Our Microbial Friends Model of Colitis | Immunity